# Dronedarone Rhythm Intervention for Early Atrial Fibrillation

Study · id `cardio:ct-nct07270848` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07270848](<https://clinicaltrials.gov/study/NCT07270848>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07270848

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1898 participants.

## Technical summary

Registry record NCT07270848. Randomized; no masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1898 participants (planned count; ClinicalTrials.gov record NCT07270848, source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)
- Planned start: 2026-01-01 (anticipated) (ClinicalTrials.gov record NCT07270848, source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT07270848, source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07270848, source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT07270848, source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07270848-2025-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dronedarone Rhythm Intervention for Early Atrial Fibrillation
- Acronym: DRIVE-AF
- Condition: Atrial Fibrillation (AF)
- Intervention (Drug): Dronedarone
- Intervention (Drug): flecainide
- Intervention (Drug): propafenone
- Lead sponsor: Inha University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Inha University Hospital (`cardio:org-inha-university-hospital`)

## Provenance

Content hash: edf331fdee675ae57bbcf65ca0ff6ab7c6821be3cadf94098048a57d969e43a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
